Regulation

LucyRx Acquires CerpassRx to Redefine Prescription Care
Business LucyRx Acquires CerpassRx to Redefine Prescription Care

Imagine a healthcare landscape where prescription costs spiral out of control, leaving patients and employers grappling with unsustainable expenses, yet a solution emerges through strategic consolidation. In a pivotal move, LucyRx, a forward-thinking pharmacy benefits manager (PBM), has acquired

How Will CMS Transform Patient Health Data with Tech Firms?
Data and Information How Will CMS Transform Patient Health Data with Tech Firms?

Imagine a healthcare system where patients can instantly access their medical records on a mobile app, seamlessly share data with providers across states, and manage chronic conditions with AI-driven tools—all without the burden of fax machines or paper forms. This vision, once a distant dream, is n

Can Arkansas Law Curb Big Pharmacy Benefit Managers?
Public Policy Can Arkansas Law Curb Big Pharmacy Benefit Managers?

Setting the Stage: A Tug-of-War in Healthcare Markets In the complex landscape of American healthcare, a fierce battle is unfolding over the unchecked power of pharmacy benefit managers (PBMs), intermediaries that dictate prescription drug pricing and access for millions of people across the

Clinical Ambient AI Platform – Review
Process Clinical Ambient AI Platform – Review

The healthcare sector is undergoing a transformation, with technology advancing at a rapid pace. One of the standout innovations is the Clinical Ambient AI Platform, showcasing remarkable progress in digital documentation and workflow automation. Amidst increasing documentation demands on

AI-Based Mammogram Analysis – Review
Public Policy AI-Based Mammogram Analysis – Review

In the complex battle against breast cancer, early detection serves as a critical first line of defense, improving survival rates and offering patients more treatment options. As the medical diagnostics industry evolves, artificial intelligence (AI) emerges as a powerful ally, reshaping breast

Differentiation Strategies in a Crowded Cell and Gene Therapy Market
Public Policy Differentiation Strategies in a Crowded Cell and Gene Therapy Market

In the evolving world of biotechnology, the cell and gene therapy sector stands out for its innovation and potential, having transitioned from a nascent experimental novelty to a formidable industry force. However, this transition has naturally introduced a new set of challenges, with heightened

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later